Literature DB >> 22467286

Reevaluating the prognostic significance of age in differentiated thyroid cancer.

Samuel L Oyer1, Valerie A Smith, Eric J Lentsch.   

Abstract

OBJECTIVE: To determine the impact of age on disease-specific survival in differentiated thyroid cancer. STUDY
DESIGN: Retrospective analysis of a large population database. Setting Surveillance, Epidemiology, and End Results (SEER) database/multiple settings. SUBJECTS AND METHODS: The SEER database was examined to identify patients diagnosed with either papillary or follicular carcinoma of the thyroid between the years 1988 and 2003. Information obtained included patient age, sex, tumor type, size, extension, and nodal or distant metastases. Kaplan-Meier survival analyses were used to estimate disease-specific survival based on patient age range, and the log-rank test was used to assess for statistical differences between survival curves. A multivariate analysis was performed including the variables listed above to determine disease-specific hazard ratios of death for various age cutoffs.
RESULTS: A total of 42,209 patients were identified. Patients 45 years and older had significantly worse survival than younger patients (P < .0001). A significant decrease in disease-specific survival was first seen in patients aged 35 years and older, and survival continued to steadily decrease with each additional decade of age (P < .001). Patients aged 35 years and older were 14 times more likely to die from differentiated thyroid cancer than patients younger than 35 years.
CONCLUSION: Increasing age is associated with poorer survival in differentiated thyroid cancer. This relationship represents a continuum with an initial decrease in survival starting at age 35 years that continues to decline with further advancing age.

Entities:  

Mesh:

Year:  2012        PMID: 22467286     DOI: 10.1177/0194599812441587

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  25 in total

1.  Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.

Authors:  Ryan K Orosco; Timon Hussain; Kevin T Brumund; Deborah K Oh; David C Chang; Michael Bouvet
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

2.  An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Laura Y Wang; Jocelyn C Migliacci; Antoine Eskander; Michael J Campbell; Ahmad Aniss; Lilah Morris; Fernanda Vaisman; Rossana Corbo; Denise Momesso; Mario Vaisman; Andre Carvalho; Diana Learoyd; William D Leslie; Richard W Nason; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; K Alok Pathak; Wen T Shen; Mark Sywak; Luis Kowalski; Jeremy Freeman; Nancy Perrier; Jatin P Shah
Journal:  Thyroid       Date:  2016-02-25       Impact factor: 6.568

3.  Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

Authors:  Ian Ganly; Iain J Nixon; Laura Y Wang; Frank L Palmer; Jocelyn C Migliacci; Ahmad Aniss; Mark Sywak; Antoine E Eskander; Jeremy L Freeman; Michael J Campbell; Wen T Shen; Fernanda Vaisman; Denise Momesso; Rossana Corbo; Mario Vaisman; Ashok Shaha; R Michael Tuttle; Jatin P Shah; Snehal G Patel
Journal:  Thyroid       Date:  2015-08-12       Impact factor: 6.568

Review 4.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

5.  Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.

Authors:  Fabián Pitoia; Fernando Jerkovich; Anabella Smulever; Gabriela Brenta; Fernanda Bueno; Graciela Cross
Journal:  Eur Thyroid J       Date:  2017-01-07

6.  Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence.

Authors:  Sona Shah; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

Review 7.  New insights in risk stratification of differentiated thyroid cancer.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

8.  Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.

Authors:  I V Shevchyk; B A Cobian; S R Martinez
Journal:  Clin Transl Oncol       Date:  2017-04-24       Impact factor: 3.405

9.  Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.

Authors:  Jianhua Feng; Fei Shen; Wensong Cai; Xiaoxiong Gan; Xingyan Deng; Bo Xu
Journal:  Endocrine       Date:  2018-06-16       Impact factor: 3.633

10.  Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; Jatin P Shah
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.